Fig. 3 | Nature Communications

Fig. 3

From: Direct quality control of glycoengineered erythropoietin variants

Fig. 3

Biological reproducibility and sialylation status of EPO clones expressing bi-antennary N-glycans. a Deconvoluted mass spectra of EPO from two biological replicate clones, C11 (top) and C12 (bottom) exhibiting variable degree of O-glycosite occupancy (Hex15HexNAc12F3 glycoproteoform), b Comparison of sialylation on EPO purified from clone C08 (mgat4A/4B/5 KO) and C12, whereby the latter has an additional st3gal4/6 KO. c Deconvoluted native mass spectrum of sialidase treated EPO purified from the C12 clone. The depicted glycan composition corresponds to the total glycan content of the most abundant mass peak. Main glycoproteoforms are color coded, wherein each color corresponds to a unique Hexx+3HexNAcxF3 composition, and the numbers above the annotated peaks indicate the number of sialic acid residues

Back to article page